Envarsus XR Dosing: 4mg vs. Three 1mg Tablets
Yes, taking Envarsus XR 4mg once daily is equivalent to taking three 1mg tablets once daily (total 3mg), but these are NOT the same total dose—4mg provides higher tacrolimus exposure than 3mg. If your question is whether you can substitute the 4mg tablet with three 1mg tablets to achieve the same dose, the answer is no—you would need four 1mg tablets to equal one 4mg tablet 1.
Key Dosing Principles
Envarsus XR tablets are bioequivalent across strengths, meaning 1mg and 4mg formulations deliver proportional tacrolimus exposure 2. The critical issue is ensuring your total daily dose matches your prescribed regimen:
- Envarsus XR 4mg once daily = 4mg total daily dose
- Envarsus XR 1mg × 3 tablets once daily = 3mg total daily dose
- These deliver different tacrolimus exposures and are not interchangeable
Tablet Strength Equivalence
The FDA-approved formulations are bioequivalent, allowing flexible dosing combinations 1, 2:
- To achieve 4mg daily: Take one 4mg tablet OR four 1mg tablets
- To achieve 3mg daily: Take three 1mg tablets (no 3mg tablet exists)
- All tablets must be taken together once daily—Envarsus XR is an extended-release formulation designed for once-daily administration 1
Critical Safety Considerations
Medication Errors Are Common and Dangerous
Envarsus XR is NOT interchangeable with other tacrolimus formulations (immediate-release tacrolimus, Astagraf XL, or generic tacrolimus) 1. Substitution errors have caused:
- Graft rejection from under-exposure
- Serious toxicity from over-exposure
- Death in some cases 1
Always verify your tablets match the prescribed formulation:
- Envarsus XR 1mg: White oval tablet, debossed "TCS" on one side and "1" on the other
- Envarsus XR 4mg: White oval tablet, debossed "TCS" on one side and "4" on the other 1
Therapeutic Drug Monitoring Is Mandatory
Regardless of which tablet strength combination you use, tacrolimus whole blood trough levels must be monitored 1:
- Measure trough levels at least twice during the first week after any dose change
- Target trough concentrations: 4-11 ng/mL for kidney transplant recipients 1
- Steady-state takes approximately 7 days to achieve 1
- More frequent monitoring needed if you have hepatic impairment, are African-American, or take interacting medications 1
Conversion Ratios (If Switching From Other Tacrolimus)
If you're converting FROM immediate-release tacrolimus TO Envarsus XR 1, 3:
- Use 80% of your total daily immediate-release dose (e.g., 5mg twice-daily immediate-release = 8mg total → switch to 6.4mg Envarsus XR once daily)
- Real-world data suggests an average conversion ratio of 1:0.73 (immediate-release to Envarsus XR) 3
Target Trough Levels for Transplant Recipients
Based on current liver transplant guidelines 4:
- First month post-transplant: 6-10 ng/mL (monotherapy) or 4-7 ng/mL (with other immunosuppressants)
- After first month: 4-8 ng/mL (monotherapy) or 3-5 ng/mL (with other immunosuppressants)
- Beyond first year: 4-6 ng/mL or lower with combination therapy
Common Pitfalls to Avoid
- Never split, crush, or chew Envarsus XR tablets—this destroys the extended-release mechanism 1
- Take all tablets at the same time once daily—do not split the dose
- Avoid grapefruit and grapefruit juice—these increase tacrolimus levels unpredictably 1
- Avoid alcohol—may affect drug release 1
- Confirm your prescription with your transplant team if pharmacy dispenses different-looking tablets 1
Bottom Line
If your prescription is for 4mg daily, you need either one 4mg tablet or four 1mg tablets taken together once daily. Three 1mg tablets (3mg total) provides 25% less tacrolimus exposure than 4mg and should only be used if specifically prescribed at that lower dose. Never adjust your tacrolimus dose without consulting your transplant physician—even small changes affect drug exposure and transplant outcomes 1, 5.